SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-16-617874
Filing Date
2016-06-09
Accepted
2016-06-09 16:33:02
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d207274d424b5.htm 424B5 519853
2 GRAPHIC g207274g07n61.jpg GRAPHIC 90560
3 GRAPHIC g207274g45y70.jpg GRAPHIC 60399
4 GRAPHIC g207274g87q10.jpg GRAPHIC 12507
5 GRAPHIC g207274g96b22.jpg GRAPHIC 33927
  Complete submission text file 0001193125-16-617874.txt   793180
Mailing Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376
Business Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-207250 | Film No.: 161706368
SIC: 2834 Pharmaceutical Preparations